43 phenotypes from 12 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Sellm1Btlr/Sellm1Btlr C57BL/6J-Sellm1Btlr	decreased single-positive T cell number	J:217794
Sellm2Btlr/Sellm2Btlr C57BL/6J-Sellm2Btlr	decreased response to antigen	J:231806
	decreased single-positive T cell number	J:231806
Selltm1.1Rpmc/Selltm1.1Rpmc involves: 129S1/Sv * C57BL/6J * FVB/N	abnormal granulocyte physiology	J:249558
	abnormal neutrophil physiology	J:249558
	normal hematopoietic system phenotype	J:249558
	normal immune system phenotype	J:249558
	increased inflammatory response	J:249558
	increased susceptibility to induced thrombosis	J:249558
	normal mortality/aging	J:249558
	normal reproductive system phenotype	J:249558
Selltm1Alb/Selltm1Alb involves: 129S7/SvEvBrd * C57BL/6	extramedullary hematopoiesis	J:70682
	normal integument phenotype	J:70682
	intermingled spleen red and white pulp	J:70682
Selltm1b(EUCOMM)Hmgu/Selltm1b(EUCOMM)Hmgu C57BL/6N-Selltm1b(EUCOMM)Hmgu/H	increased spleen weight	J:211773
Selltm1Flv/Sell+ involves: C57BL/6 * NOD	decreased susceptibility to autoimmune diabetes	J:88947
	pancreas inflammation	J:88947
Selltm1Flv/Sell+ NOD.Cg-Selltm1Flv	normal immune system phenotype	J:88974
Selltm1Flv/Selltm1Flv involves: 129S2/SvPas * C57BL/6	abnormal type IV hypersensitivity reaction	J:89253
	decreased activated T cell number	J:89253
Selltm1Flv/Selltm1Flv involves: C57BL/6 * NOD	decreased susceptibility to autoimmune disorder	J:88947
	pancreas inflammation	J:88947
Selltm1Flv/Selltm1Flv NOD.Cg-Selltm1Flv	normal immune system phenotype	J:88974
Selltm1Pest/Sell+ involves: 129S4/SvJae * C57BL/6	abnormal hypersensitivity reaction	J:112550
	impaired leukocyte tethering or rolling	J:112550
Selltm1Pest/Selltm1Pest involves: 129S4/SvJae	abnormal hypersensitivity reaction	J:111233
	abnormal leukocyte adhesion	J:111233
	impaired leukocyte tethering or rolling	J:111233
	increased T cell proliferation	J:111233
Selltm1Pest/Selltm1Pest involves: 129S4/SvJae * C57BL/6	abnormal cell-mediated immunity	J:112550
	abnormal dendritic cell physiology	J:112550
	abnormal hypersensitivity reaction	J:112550
	abnormal leukocyte migration	J:112550
	abnormal splenic cell ratio	J:112550
	decreased T cell proliferation	J:112550
	enlarged spleen	J:112550
	normal immune system phenotype	J:112550
	impaired leukocyte tethering or rolling	J:112550
	lymph node hypoplasia	J:112550
	small popliteal lymph nodes	J:112550
Selltm1Tft/Selltm1Tft B6.129-Selltm1Tft	abnormal cellular extravasation	J:66107
	abnormal leukocyte migration	J:66107
Selltm1Tft/Selltm1Tft B6.129P2-Selltm1Tft	abnormal cellular extravasation	J:48271
	abnormal regulatory T cell number	J:141931
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:48271
	increased monocyte cell number	J:48271, J:142184
	increased tumor growth/size	J:108135
	lymph node hypoplasia	J:141931, J:142184
	spleen hyperplasia	J:141931
Selltm1Tft/Selltm1Tft involves: 129P2/OlaHsd * C57BL/6	abnormal cellular extravasation	J:25005
	abnormal leukocyte migration	J:25005
	enlarged spleen	J:25005
	impaired leukocyte tethering or rolling	J:25005
Selltm2.1Tft/Selltm2.1Tft involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal circulating protein level	J:142184
	abnormal neutrophil physiology	J:142184
	spleen hyperplasia	J:142184
Selltm2Hyn/Selltm2Hyn involves: 129S2/SvPas * BALB/c	impaired leukocyte tethering or rolling	J:114317
Selltm2Hyn/Selltm2Hyn involves: 129S2/SvPas * C57BL/6	decreased metastatic potential	J:106671
	decreased monocyte cell number	J:57973
	decreased tumor incidence	J:106671
	normal immune system phenotype	J:106550
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
	normal liver/biliary system phenotype	J:106550
Selltm2Tft/Selltm2.1Tft involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal circulating protein level	J:142184
	abnormal leukocyte migration	J:142184
	abnormal neutrophil physiology	J:142184
	abnormal regulatory T cell number	J:141931
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:142184
Selltm2Tft/Selltm2Tft involves: 129S1/Sv * 129X1/SvJ	lymph node hypoplasia	J:142184
	spleen hyperplasia	J:142184
Selltm3Tft/Selltm3Tft involves: 129S1/Sv * 129X1/SvJ	abnormal circulating protein level	J:142184